Heart Failure Med Adherence Tied to Neighborhood Socioeconomic Status
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 15, 2023 -- People with heart failure who live in neighborhoods with higher levels of poverty and unemployment are less likely to fill their drug prescriptions, according to a study published online Dec. 14 in JAMA Network Open.
Amrita Mukhopadhyay, M.D., from the NYU Grossman School of Medicine in New York City, and colleagues examined the association between neighborhood-level socioeconomic status (nSES) and medication nonadherence among patients with heart failure with reduced ejection fraction. Analysis included 6,247 adult patients seen at a single health system (June 30, 2020, to Dec. 31, 2021).
The researchers found that patients in lower nSES areas had higher rates of nonadherence (ranging from 51.7 percent in the lowest quartile to 40.0 percent in the highest quartile). Patients living in the lower two nSES quartiles had significantly higher odds of nonadherence versus patients living in the highest nSES quartile in adjusted analysis (odds ratios, 1.57 and 1.35 for quartiles 1 and 2, respectively). Access to transportation and pharmacy density did not mediate results; results were mediated slightly by neighborhood walkability.
"These findings highlight the importance of considering neighborhood-level disparities when developing approaches to improve medication adherence," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Gains in Heart Failure Mortality Have Been Erased
FRIDAY, April 26, 2024 -- Declines in heart failure-related mortality from 1999 to 2012 were entirely reversed from 2012 to 2021, according to a research letter published online...
Reports of Injuries, Deaths Prompt FDA to Recall Heart Failure Devices
WEDNESDAY, April 17, 2024 -- The HeartMate II and HeartMate 3, manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories, are now under a strict U.S. Food and Drug...
American College of Cardiology, April 6 to 8
The annual meeting of the American College of Cardiology was held from April 6 to 8 in Atlanta and attracted more than 12,000 participants, including clinicians, academicians...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.